BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9342577)

  • 1. Structure and activities of hospital drug committees in Germany.
    Thürmann PA; Harder S; Steioff A
    Eur J Clin Pharmacol; 1997; 52(6):429-35. PubMed ID: 9342577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].
    Harder S; Thürmann P; Steioff A
    Med Klin (Munich); 1998 Feb; 93(2):119-24. PubMed ID: 9545712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
    Fijn R; Brouwers JR; Knaap RJ; De Jong-Van Den Berg LT
    Br J Clin Pharmacol; 1999 Aug; 48(2):239-46. PubMed ID: 10417503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals.
    Puigventós F; Santos-Ramos B; Ortega A; Durán-García E
    Pharm World Sci; 2010 Dec; 32(6):767-75. PubMed ID: 20820918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 9. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
    Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.
    Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1255-1262. PubMed ID: 30451035
    [No Abstract]   [Full Text] [Related]  

  • 13. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of drug and therapeutics committees operating in Ireland.
    Ferrando MC; Henman MC
    J Clin Hosp Pharm; 1986 Apr; 11(2):131-40. PubMed ID: 3711361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug and Therapeutics Committees in Australia: expected and actual performance.
    Weekes LM; Brooks C
    Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
    Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
    Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-tier drugs assessment in a decentralised health care system. The Italian case-study.
    Jommi C; Costa E; Michelon A; Pisacane M; Scroccaro G
    Health Policy; 2013 Oct; 112(3):241-7. PubMed ID: 23850166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.